The Effects of N-acetylcysteine on Performance and Redox Homeostasis

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

February 15, 2016

Study Completion Date

September 12, 2016

Conditions
Glutathione Metabolism Anemias
Interventions
DRUG

N-acetylcysteine

The antioxidant group received orally two N-acetylcysteine tablets (each tablet contained 600 mg of NAC; Lamberts Health Care Ltd, Kent, United Kingdom). The participants were instructed to receive the capsules every twelve hours in order to achieve high concentration of N-acetylcysteine throughout the 24 h. Each individual received the capsules pre-packed in daily doses labeled with the day of consumption. The supplementation period was 30-day for N-acetylcysteine.

DRUG

Lactose

The placebo group received orally two lactose tablets per day. The participants were instructed to receive the capsules every twelve hours. Each individual received the capsules pre-packed in daily doses labeled with the day of consumption. The supplementation period was 30-day for placebo.

Trial Locations (3)

1516

European University Cyprus, Nicosia

17237

National and Kapodistrian University of Athens, Athens

54124

Aristotle University of Thessaloniki, Thessaloniki

All Listed Sponsors
collaborator

National and Kapodistrian University of Athens

OTHER

collaborator

European University Cyprus

OTHER

lead

Aristotle University Of Thessaloniki

OTHER

NCT03121222 - The Effects of N-acetylcysteine on Performance and Redox Homeostasis | Biotech Hunter | Biotech Hunter